Caitong International Asset Management Co., LTD 89bio, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in 89bio, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 61 shares of ETNB stock, worth $506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 61
-0.0%
Holding current value
$506
Previous $477,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
178Shares Held
131MCall Options Held
78.7KPut Options Held
963K-
Janus Henderson Group PLC London, X016.5MShares$137 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$118 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$84.7 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$62.1 Million0.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$59.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $386M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...